02 September 2022>: Clinical Research
Comparative Evaluation of 3 Commercial Mouthwash Formulations on Clinical Parameters of Chronic Gingivitis
Shahabe Saquib Abullais 1ABFG , Sabiha Ilyas Patel 2ADEF , Elyas Ali Asiri 3ABCE , Adel Ali Ahmed Jathmi 3ABE , Afnan Hassan Alkhayri 3ADEG , Yosra Mohammed Mousa 3BEFG , Atheer Abdulhade Ganem 4BCE , Khurshid A. Mattoo 5CDE*DOI: 10.12659/MSM.937111
Med Sci Monit 2022; 28:e937111
Table 2 Comparative mean scores of clinical parameters among patients in various groups and the respective level of significance between various groups at different intervals of time.
Clinical parameters | Group 1 (CHX) | Group 2 (Manuka) | Group 3 (ProB) | P-value (Inter-Group) | |||
---|---|---|---|---|---|---|---|
Mean±SD | Mean±SD | Mean±SD | Group 1 vs group 2 | Group 1 vs group 3 | Group 2 vs group 3 | ||
Plaque Index | Baseline | 1.35±0.23 | 1.43±0.21 | 1.31±0.16 | 0.883 | 0.999 | 0.356 |
Day 7 | 0.73±0.14 | 0.79±0.15 | 0.92±0.16 | 0.840 | 0.004** | 0.078 | |
Day 14 | 0.69±0.13 | 0.61±0.18 | 0.81±0.15 | 0.399 | 0.155 | 0.003** | |
Day 28 | 0.66±0.11 | 0.71±0.15 | 0.87±0.13 | 0.999 | 0.001*** | 0.004** | |
Gingival Index | Baseline | 1.35±0.12 | 1.39±0.19 | 1.41±0.23 | 0.999 | 0.999 | 0.999 |
Day 7 | 0.75±0.15 | 0.76±0.10 | 0.98±0.15 | 0.999 | 0.001*** | 0.001*** | |
Day 14 | 0.66±0.20 | 0.57±0.21 | 0.85±0.16 | 0.562 | 0.031* | 0.001*** | |
Day 28 | 0.61±0.16 | 0.61±0.19 | 0.89±0.14 | 0.999 | 0.001*** | 0.001*** | |
Bleeding Index | Baseline | 0.93±0.17 | 0.98±0.16 | 1.03±0.17 | 0.999 | 0.330 | 0.999 |
Day 7 | 0.47±0.17 | 0.45±0.11 | 0.61±0.13 | 0.999 | 0.024* | 0.008** | |
Day 14 | 0.45±0.17 | 0.33±0.17 | 0.54±0.10 | 0.086 | 0.385 | 0.001*** | |
Day 28 | 0.46±0.15 | 0.38±0.19=7 | 0.55±0.10 | 0.411 | 0.324 | 0.009** | |
CHX – chlorhexidine; ProB – probiotics; vs – versus. Levels of significance: NS (not-significant)=P≥0.05; * Significant=P ** Very significant=P *** Highly significant=P |